President Donald Trump wants a U.S. investor to take a major stake in ByteDance’s TikTok. Several parties are in contention ...
Big Tech’s multi-billion dollar spending on artificial intelligence will be under investor scrutiny this week — even more so ...
The surprise success of China’s AI startup, DeepSeek, led to tech stocks being hammered in the US market. Nvidia, the leading ...
Several prominent figures have expressed interest in acquiring TikTok, though the terms of any potential purchase remain ...
The company said Friday it develops medicines designed to precisely target disease pathology with an initial emphasis on the innate immune system. Odyssey said its most advanced programs include ...
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...
(NASDAQ:ARGX – Get Free Report)‘s stock had its “buy” rating restated by analysts at Truist Financial in a research report issued on Tuesday,Benzinga reports. They currently have a $700.00 price ...
Wedbush analysts view the technology selloff this morning as a “golden buying opportunity.” No U.S. global 2000 company is going to use a ...